Data Characteristics
R&D documents for attenuated and inactivated vaccines typically include preclinical study reports, strain screening records, manufacturing process protocols, quality control standards, stability study data, and clinical trial protocols. Data sources are diverse, encompassing internal laboratory records, reports from collaborating institutions, and regulatory submission materials. Document update frequency is high, especially during clinical trials, where data continuously generates with batch production and subject enrollment. Document structures are primarily unstructured and semi-structured text, such as experimental logs, meeting minutes, and expert review opinions. They also contain structured data tables, like potency, purity, and toxicity indicators in batch analysis reports. Fields and units are specialized within the biomedical domain, for example, titer (TCID50/mL), purity (%), and antigen content (μg/mL).
Constraints on Reference Sourcing and Traceability
The characteristics of attenuated and inactivated vaccine R&D documents impose specific requirements on reference sourcing and traceability. Frequent document updates necessitate that the knowledge base supports efficient version management and incremental updates to ensure reference timeliness. Diverse and heterogeneous data formats require structured parsing to be compatible with various file types and accurately extract key information. Highly specialized fields and units, along with their potential ambiguity (e.g., qualitative descriptions like "low toxicity," "high purity"), require clear context when referenced to avoid misinterpretation. Furthermore, the multiple parties involved in R&D and strict compliance requirements make precise traceability of referenced content to original documents, authors, and timestamps essential for audit and regulatory adherence.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 800–1200 characters | Individual experimental steps or result descriptions in vaccine R&D documents typically fall within this length, aiding context comprehension. |
Chunk Overlap Length (Segment Overlap Length) | 100 characters | Ensures contextual continuity and prevents critical information from being cut off. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Guarantees high relevance of recall results to the query intent, reducing inaccurate references. |
Recall count (Number of Retrieved Items) | 5–8 items | Balances recall breadth with processing efficiency, satisfying the need for multi-perspective information verification. |
Rerank result count (Number of Reranked Items) | 3 items | Focuses on the most relevant references, improving the precision of the final presentation. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Large R&D reports may contain numerous charts and complex layouts, requiring longer parsing times. |
Common Pitfalls
- Referenced document snippets in query results lack context, leading to semantic ambiguity. This occurs when the segment length is set too short, failing to retain complete critical information.
- The original file version pointed to by the reference source is incorrect. This happens when the knowledge base does not correctly handle document version updates, leading to erroneous referencing of outdated information.
- When retrieving batch reports, the results fail to distinguish potency data from different batches. This occurs when the vector database cannot effectively identify and differentiate subtle differences in specialized fields (e.g.,
batch number) within documents, affecting recall precision.
How to Verify Configuration
- Submit a query containing specific experimental data and conclusions. Check if the returned reference snippets are complete and clearly present the original context.
- Update an R&D document already in the knowledge base. Then, query for old information within that document. Check if the reference points to the new version or clearly indicates version differences.
- Ask questions about quality control indicators for a specific vaccine batch. Verify if the referenced results accurately trace back to the specific report and data items for that batch.
The values given are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.